Ogino M, Fujii T, Koibuchi Y, Nakazawa Y, et al. Phase II Study of Nab-paclitaxel Plus Cyclophosphamide Plus Trastuzumab Neoadjuvant Chemotherapy in Early HER-2-positive Breast Cancer. Anticancer Res 2021;41:3899-3904.
PMID: 34281852